Masson, W., Solís, C. and Nogueira, J.P. 2026. Semaglutide and Metabolic Dysfunction–Associated Fatty Liver Disease: A Systematic Review. Acta Gastroenterológica Latinoamericana. 56, 1 (Mar. 2026), 59–70. DOI:https://doi.org/10.52787/agl.v56i1.591.